Dr. Barankin was quoted in the February 2013 issue of The Chronicle of Skin & Allergy in an article entitled “Therapies to watch for in 2013.” In this article, Dr. Barankin discusses Botox, as well as the new botulinum toxin Dysport and their differences. He is also quoted discussing the new Minoxidil 5% foam for hair loss and its benefits compared to old formulations. Dr. Barankin is also quoted discussing the use of endermologie to improve the appearance of the skin. He also discusses miraDry which is a new laser on the horizon for hyperhidrosis (excessive sweating), and how it fits into the treatment armamentarium of dermatologists. Finally, Dr. Barankin is also quoted on the use of new oral biologic therapies for psoriasis; traditionally the biologic drugs for psoriasis have been given by subcutaneous injection or infusion.
By: Dr Ben Barankin